LPCAT3
Basic information
Region (hg38): 12:6976185-7018477
Previous symbols: [ "OACT5", "MBOAT5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LPCAT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 1 |
Variants in LPCAT3
This is a list of pathogenic ClinVar variants found in the LPCAT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-6977155-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
12-6977182-C-T | not specified | Uncertain significance (Nov 12, 2024) | ||
12-6977208-T-C | not specified | Uncertain significance (Feb 08, 2023) | ||
12-6977229-A-T | not specified | Uncertain significance (Nov 08, 2022) | ||
12-6977231-A-G | not specified | Uncertain significance (Sep 29, 2023) | ||
12-6977497-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
12-6977725-T-C | not specified | Uncertain significance (Jun 08, 2022) | ||
12-6978348-C-G | not specified | Uncertain significance (Nov 29, 2021) | ||
12-6978357-T-G | not specified | Uncertain significance (Jan 23, 2023) | ||
12-6978380-A-G | not specified | Uncertain significance (Jun 29, 2022) | ||
12-6978389-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
12-6978441-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
12-6978659-T-C | not specified | Uncertain significance (Jul 14, 2022) | ||
12-6981145-C-G | not specified | Uncertain significance (Nov 04, 2022) | ||
12-6981606-C-T | not specified | Uncertain significance (Nov 07, 2024) | ||
12-6981860-G-A | Benign (Dec 31, 2019) | |||
12-6981868-C-T | not specified | Uncertain significance (Sep 06, 2024) | ||
12-6981910-A-G | Benign (Dec 31, 2019) | |||
12-6982696-T-C | not specified | Uncertain significance (Apr 13, 2023) | ||
12-6982702-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
12-6982716-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
12-6982722-A-G | not specified | Uncertain significance (Oct 27, 2021) | ||
12-6982732-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
12-6982764-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
12-6983477-G-A | not specified | Uncertain significance (Aug 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LPCAT3 | protein_coding | protein_coding | ENST00000261407 | 12 | 40467 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.995 | 0.00492 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.45 | 153 | 266 | 0.576 | 0.0000134 | 3164 |
Missense in Polyphen | 46 | 105.89 | 0.4344 | 1246 | ||
Synonymous | -0.117 | 107 | 105 | 1.01 | 0.00000546 | 945 |
Loss of Function | 4.47 | 3 | 29.0 | 0.104 | 0.00000150 | 325 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.000103 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3- phosphocholine or PC) (LPCAT activity). Catalyzes also the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero- 3-phospho-L-serine or LPS) into phosphatidylserine (1,2-diacyl-sn- glycero-3-phospho-L-serine or PS) (LPSAT activity). Has also weak lysophosphatidylethanolamine acyltransferase activity (LPEAT activity). Favors polyunsaturated fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs. Seems to be the major enzyme contributing to LPCAT activity in the liver. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle. {ECO:0000269|PubMed:18195019, ECO:0000269|PubMed:18772128}.;
- Pathway
- Glycerophospholipid metabolism - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;Acyl chain remodelling of PC;triacylglycerol biosynthesis;Acyl chain remodelling of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acyl chain remodelling of PE
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.404
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.73
Haploinsufficiency Scores
- pHI
- 0.295
- hipred
- Y
- hipred_score
- 0.658
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lpcat3
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- phospholipid biosynthetic process;phosphatidylserine acyl-chain remodeling;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;regulation of plasma lipoprotein particle levels
- Cellular component
- endoplasmic reticulum membrane;membrane;integral component of membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;2-acylglycerol-3-phosphate O-acyltransferase activity;1-acylglycerophosphocholine O-acyltransferase activity